
Number of publications published per year by Houghton, Michael. (Source : PubMed)

Distribution of publications types for Houghton, Michael. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)


The long and winding road leading to the identification of the hepatitis C virus.
J. Hepatol.
2009;51;5


Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers.
Human vaccines
2009;5;3


Discovery of the hepatitis C virus.
Liver Int.
2009;29 Suppl 1
Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5.
J. Virol.
2008;82;15

Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection.
J. Virol.
2008;82;10

The way forward in HCV treatment--finding the right path.
Nat Rev Drug Discov
2007;6;12

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies.
Vaccine
2007;25;45


Characterization of an immunodominant antigenic site on GB virus C glycoprotein E2 that is involved in cell binding.
J. Virol.
2006;80;24
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.
J. Gen. Virol.
2006;87;Pt 8

Preparing for the oral exam.
Practitioner
2006;250;1678
[ See timeline ] [ See all publications ]
means that Houghton, Michael has 56 papers cited a least 56 times - methodology
Novartis Vaccine and Diagnostic, Inc., Emeryville, California 94608, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.